HOME >> BIOLOGY >> NEWS
Federally Sponsored Panel To Look At Data On Plasticizers: Do They Harm Reproduction, Or Children's Development?

The federal government's new reproductive risk evaluation center today announced its first review -- a look at the possible reproductive risks to plastics workers and consumers from seven phthalates found widely in consumer products and the environment. Phthalates are chemical plasticizers used in making flexible vinyl products such as shower curtains, medical devices such as tubing and IV bags, upholstery, raincoats, balls and soft squeeze toys.

The new NTP Center for the Evaluation of Risks to Human Reproduction will assemble a dozen or more scientists with applicable expertise to evaluate the substances in public sessions, according to a center announcement in the Federal Register. The sessions are tentatively planned for August in the Washington, D.C., area.

The center asked scientists to share their latest data on the substances to be reviewed: butyl benzyl phthalate, di(2-ethylhexyl) phthalate, di-isodecyl phthalate, di-isononyl phthalate, di-n-butyl phthalate, di-n-hexyl phthalate, and di-n-octyl phthalate.

The National Institute of Environmental Health Sciences and the National Toxicology Program, which is headquartered at NIEHS, in January announced the creation of the NTP Center for the Evaluation of Risks to Human Reproduction to evaluate risks to human reproduction and child development for regulatory agencies and the public -- and to point to gaps in knowledge that need to be filled by additional research and testing.

"A decline in human sperm counts over recent decades has been reported but not confirmed," officials said in the January announcement, adding that 5 to 10 percent of couples who want children cannot get pregnant and 3 to 5 percent of newborns have major birth defects.

"The panel will look at data to see how likely it may be that phthalates contribute to these reproductive and developmental problems," Michael Shelby, Ph.D., chief of the Laboratory of Toxic
'"/>

Contact: Bill Grigg
grigg@niehs.nih.gov
301-402-3378
NIH/National Institute of Environmental Health Sciences
12-Apr-1999


Page: 1 2

Related biology news :

1. NTP-CERHR announces the Second Phthalates Expert Panel Meeting to be held December 15-17, 1999
2. Science, technology, and the future: Panel discussion to be held November 1, 1999
3. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
4. Childrens eating patterns show striking changes in two decades
5. Childrens Memorial, TGen announce partnership
6. Federal grant supports advances in infant heart disease at Childrens Hospital of Philadelphia
7. Packard Childrens Hospital gift creates new biotech research center for childrens health
8. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician
9. Childrens Hospital Boston researchers regenerate zebrafish heart muscle
10. Childrens Hospital Boston researchers use therapeutic cloning to create functional tissue in cows
11. Childrens book explores why animals stay home to help

Post Your Comments:
(Date:5/23/2013)... Pacific Northwest National Laboratory honored more than ... of intellectual property at PNNL,s annual Intellectual Property ... The Department of Energy national laboratory named materials ... his work developing battery materials that can store ... electrical grid, and reduce the time it takes ...
(Date:5/23/2013)... 284 million tons of cargo, transit the Panama Canal each ... the Panama Canal Authority. Each time a ship passes through, ... Gatun Lake, which is also a source of water for ... However, the advent of very large "super" cargo ships, now ... demanded change. The Panama Canal is being expanded to create ...
(Date:5/23/2013)... Health at Emory University, along with partners at ... $4 million grant over four years to establish ... Exposome Research Center: Understanding Lifetime Exposures). The grant ... the United States. , The HERCULES Center ... Health Sciences (NIEHS) of the National Institutes of ...
Breaking Biology News(10 mins):PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
(Date:5/23/2013)... 2013 Graphite Metallizing Corporation announces ... mounted in stainless steel pillow blocks. This series ... with the application and installation versatility of pillow ... work exceptionally well when submerged in water, ... such as acids, alkalies, hydrocarbons, black liquor, and ...
(Date:5/23/2013)... The maker community is a contemporary group ... focus on learning practical skills while applying them creatively ... their ideas to life via crowdfunding. A subgroup within ... projects using biology. Glowing Plant has worked for months ... glow with bioluminescence genes, and has now pursued crowdfunding ...
(Date:5/23/2013)... Virobay, Inc. today announced that their development ... important milestone, as Virobay has now initiated a Phase ... S inhibitor.   The first Phase 1 ... designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics ... "The initiation of this Phase 1 trial with ...
(Date:5/23/2013)... 23, 2013 Northwest Biotherapeutics (NASDAQ: ... ® personalized immune therapies for solid tumor cancers, ... this year,s American Society Of Clinical Oncology (ASCO) meeting ... leadership role in immune therapy.  (Logo: ... is the pre-eminent conference focused on clinical treatment of ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: